Skip to main content

Resource Library


16 July 2024

The forthcoming U.S. BIOSECURE Act is already making an impact on the China business strategy of global pharmaceutical companies. What are the implications for your China risk exposure?

Blog
Biopharmaceutical companies worldwide have expressed their intentions to continue investing in China. However, the forthcoming U.S. BIOSECURE Act means that many are proactively reassessing their China business strategies. Pamir has been working with pharma
ANALYST PAPER - CHINA AND RUSSIA COOPERATION

How are China and Russia advancing their shared agendas?

Download our recent analyst paper to understand the key implications of recent China-Russia diplomatic developments.


Resource Library

21 January 2025

China’s Increasingly Risky Business Environment Prompts Foreign Firms to Relocate Operations to Other Asian Countries

Blog
In anticipation of the incoming Trump administration’s tariffs and sanctions against the People’s Republic of China (PRC), a growing number of foreign companies, particularly semiconductor manufacturers, are moving their production facilities to countries neighboring the PRC. This development reflects China’s increasingly risky business environment.
18 December 2024

China Is Expanding Its Footprint in Latin America and the Caribbean

Blog
The recent China-Peru joint inauguration of the Chancay Port is the latest example of the People’s Republic of China (PRC)’s growing influence in Latin America and the Caribbean (LAC).
16 December 2024

Hong Kong’s Eroding Autonomy Adds Risks to Its Business Environment

Blog
In November, 45 Hong Kong politicians, activists, union officials, academics, and student leaders were sentenced to up to 10 years in prison on the charge of subversion under the national security laws of the People’s Republic of China (PRC) and the Hong Kong Special Administrative Region (HKSAR).
Make contact with Pamir

Ready to get started on your
China strategy?

Get in touch with us